Panobinostat (MTX110)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Panobinostat (MTX110), covering 2025-03-10 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults with Recurrent Medulloblastoma [EARLY_Phase 1]